Table 3 Symptomatic relief due to various treatments.

From: An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients

Treatment

Days to become afebrile

Days for cough reduction

Days for myalgia reduction

Median

95% CI

IQR

Median

95% CI

IQR

Median

95% CI

IQR

Indomethacin

3

3.0, 3.0

1

4

4.0, 5.0

1

4

3.0, 4.0

2

Paracetamol

7

6.0, 7.0

2.75

7

7.0, 8.0

3

7

5.0, 7.0

2